23 years of the discovery of Helicobacter pylori: Is the debate over?

Annals of Clinical Microbiology and Antimicrobials

Volumn 4, Issue , 2005, Pages

  Ahmed, Niyaz ^a  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACHIEVEMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CLINICAL MEDICINE; EDITORIAL; GASTROINTESTINAL DISEASE; GENETIC VARIABILITY; GRAM NEGATIVE BACTERIUM; HEALTH CARE ORGANIZATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MEDICAL RESEARCH; MICROORGANISM; NONHUMAN; PATHOGENESIS; POPULATION RESEARCH; RISK BENEFIT ANALYSIS; STOMACH BIOPSY; SWEDEN; MICROBIOLOGY; PATHOGENICITY; PEPTIC ULCER; STOMACH; STOMACH TUMOR;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; STOMACH; STOMACH NEOPLASMS;

EID: 27744486020     PISSN: 14760711     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-4-17     Document Type: Article

References (13)

1. Dunn B E, Cohen H, Blaser M J: Helicobacter pylori. Clin Microbiol Rev 1997, 10: 720-741.
2. Blaser MJ: An endangered species in the stomach. Sci Am 2005, 292: 38-45
3. Marshall BJ, Warren RM: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 16:1311-1315.
4. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ: Attempt to fulfill Koch's postulates for pyloric campylobacter. Medical J Australia 1985, 142: 436-439
5. Ahmed N and Sechi LA: Helicobacter pylori and gastroduodenal pathology: new threats of the old friend. Ann Clin Microbiol Antimicrobials 2005, 4: 1
6. Putsep K, Branden C I, Boman H G, Normark S: Antibacterial peptide from H. pylori. Nature 1999, 398: 671-672.
7. Rothenbacher D, Blaser M J, Bode G, Brenner H: Inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study. J Infect Dis 2000, 182: 1446-1449.
8. Richter J E, Folk G W, Vaezi M F: Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad. Am J Gastroenterol 1999, 93:1800-1802.
9. de Martel C, Llosa A E, Farr S M, Friedman GD, Vogelman JH, Orentreich N, Corley DA, Parsonnet J: Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis 2005, 191: 761-767.
10. Chow W H, Blaser M J, Blot W J, Gammon M D, Vaughan, T L, Risch H A, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF Jr.: An Inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998, 58: 588-590.
11. Graham D Y: Helicobacter pylori, GERD, NSAIDs, and cancer: where we really stand. Am J Gastroenterol 1999, 94: 1420-1421.
12. Warburton-Timms V J, Charlett A., Valori R M, Uff J S, Shepherd N A, Barr H, McNulty CA: The significance of cagA(+) Helicobacter pylori in reflux oesophagitis. Gut 2001, 49: 341-346.
13. Pavithran K, Doval D C, Pandey KK: Gastric cancer in India. Gastric Cancer 2002, 5: 240-243.